Finance

Lists
Why is CNSP up 3,08%?
Dive Deeper
CNSP:NASDAQ
CNS Pharmaceuticals Inc
5,35 US$
+3,08%
(+0,16) 1D
13 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNSP...
Open
5,13 US$
High
5,40 US$
Low
5,00 US$
Mkt. cap
7,82 მლნ.
Avg. vol.
4,49 ათ.
Volume
14,20 ათ.
52-wk high
10,54 US$
52-wk low
1,90 US$
EPS
-23,14 US$
Beta
1,02
Shares outstanding
1,46 მლნ.
No. of employees
8
Open
5,13 US$
High
5,40 US$
Low
5,00 US$
Mkt. cap
7,82 მლნ.
Avg. vol.
4,49 ათ.
Volume
14,20 ათ.
52-wk high
10,54 US$
52-wk low
1,90 US$
EPS
-23,14 US$
Beta
1,02
Shares outstanding
1,46 მლნ.
No. of employees
8
News stories
From web sources and news partners
About CNS Pharmaceuticals Inc
CEO-
Employees8
Founded2017
Headquartersჰიუსტონი, ტეხასი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websitecnspharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
10,00 US$
+86,9%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,20 მლნ.
3,17 მლნ.
3,54 მლნ.
1,20 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,06 მლნ.
2,82 მლნ.
1,43 მლნ.
1,50 მლნ.
Operating expense
3,25 მლნ.
5,99 მლნ.
4,98 მლნ.
2,70 მლნ.
Total operating expenses
3,25 მლნ.
5,99 მლნ.
4,98 მლნ.
2,70 მლნ.
Operating income
-3,25 მლნ.
-5,99 მლნ.
-4,98 მლნ.
-2,70 მლნ.
Other non operating income
-
-2,56 ათ.
-
-
EBT including unusual items
-3,22 მლნ.
-5,96 მლნ.
-4,94 მლნ.
-2,59 მლნ.
EBT excluding unusual items
-3,22 მლნ.
-5,96 მლნ.
-4,94 მლნ.
-2,59 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,22 მლნ.
-5,96 მლნ.
-4,94 მლნ.
-2,59 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
37,02 ათ.
35,60 ათ.
44,27 ათ.
116,00 ათ.
Interest expense
-2,12 ათ.
-2,72 ათ.
-6,11 ათ.
-4,00 ათ.
Net interest expenses
34,91 ათ.
32,88 ათ.
38,16 ათ.
112,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,25 მლნ.
-5,99 მლნ.
-4,97 მლნ.
-2,69 მლნ.
Gain or loss from assets sale
-
2,56 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები